Spotlight
Clinical
Blog
Partners
Subscribe
CE
- Therapeutic Cataract & Refractive
- Lens Technology
- Glasses
- Ptosis
- Comprehensive Eye Exams
- AMD
- COVID-19
- DME
- Ocular Surface Disease
- Optic Relief
- Geographic Atrophy
- Cornea
- Conjunctivitis
- LASIK
- Myopia
- Presbyopia
- Allergy
- Nutrition
- Pediatrics
- Retina
- Cataract
- Contact Lenses
- Lid and Lash
- Dry Eye
- Glaucoma
- Refractive Surgery
- Comanagement
- Blepharitis
- OCT
- Patient Care
- Diabetic Eye Disease
- Technology
VEW 2022: New dark adaptation modality and other pipeline updates from Heru
Brandon Barber, chief marketing officer at Heru, shares about the company's new dark adaptation modality, which they announced during the 2022 Vision Expo West, as well as other advancements in the pipeline.
Brandon Barber, chief marketing officer for Heru, sat down with Optometry Times® editor, Kassi Jackson, to share about the company's new AMD portfolio expansion, and other items in the pipeline.
Related: Heru expands AMD portfolio with new launch
Key takeaways from the interview:
- Heru's latest dark adaptation modality. This new technology allows Heru to offer the only AMD portfolio available on the market.
- The company is providing cloud-based updates for their platform on a weekly and monthly basis to improve customer and patient outcomes.
- New therapeutic technology is coming out of their research facility in Bascom Palmer Eye Institute, including AR platform adaptations to improve eye defects that lead to limited vision for patients.
- Barber said that in the next 24 to 36 months, there will be advancements in the areas of AR and VR.
- These new and coming advancements improve patient experience, as well as will improve the ability for optometrists to "speed more patients through their practice," according to Barber.
Related Content
